Goosehead Insurance, Inc.·4

Sep 3, 6:36 PM ET

Colby Mark S. 4

4 · Goosehead Insurance, Inc. · Filed Sep 3, 2021

Insider Transaction Report

Form 4
Period: 2021-08-30
Colby Mark S.
Chief Financial Officer
Transactions
  • Sale

    Class A Common Stock

    2021-09-01$140.00/sh522$73,0800 total
  • Exercise/Conversion

    Class A Common Stock

    2021-08-30$10.00/sh+0$08,488 total
  • Exercise/Conversion

    Class A Common Stock

    2021-09-01$10.00/sh+0$010,000 total
  • Sale

    Class A Common Stock

    2021-08-30$140.27/sh7,611$1,067,595877 total
  • Sale

    Class A Common Stock

    2021-09-30$141.28/sh877$123,9030 total
  • Sale

    Class A Common Stock

    2021-09-01$150.43/sh9,478$1,425,776522 total
  • Exercise/Conversion

    Employee Stock Options (right to buy)

    2021-09-01040,000 total
    Exercise: $10.00Exp: 2028-04-26Class A Stock (0 underlying)
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.03 to $141.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.00 to $150.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.07 to $151.33, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
  • [F5]One third (1/3rd) of the shares subject to the option shall vest and become exercisable, subject to continued employment, on each of the second, third and fourth anniversaries of the grant date; provided, that all shares subject to the option will vest and become exercisable if Mr. Colby's employment is terminated without "cause" or for "good reason" (each as defined in either Mr. Colby's option award agreement or the issuer's omnibus incentive plan) within six month following a "change in control" (as defined in the issuer's omnibus incentive plan).

Documents

1 file
  • 4
    wf-form4_163070858536319.xmlPrimary

    FORM 4